The present invention relates to a compound of the following formula:
##STR00001## where R.sup.1-R.sup.6, R.sup.10, Y, n, m, p, and q are as
defined herein. Compounds and compositions of the present invention are
useful for the treatment of diseases associated with the overexpression
of CCR2.